Example: Heart Attack
Clinical Trials Sponsored by David Suskind
Total 2 results
-
NCT02213835CompletedCrohn's Disease Ulcerative Colitis
-
NCT01757964CompletedCrohn's Disease Ulcerative Colitis Inflammatory Bowel Disease CD
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Show vendors
Sponsors and Collaborators
- Hospital, Vannes
- Charlotte Gastroenterology and Hepatology
- First Hospital of Shijiazhuang City
- Novartis Pharmaceuticals
- Assistance Publique - Hôpitaux de Paris
- Mayo Clinic
- M.D. Anderson Cancer Center
- Mid-Atlantic Nutrition Obesity Research Center
- Universitätsklinikum Tulln
- GlaxoSmithKline
- Pfizer
- BKK Mobil Oil
- Assiut University
- Cairo University
- Amphia Hospital
- John Kempen
- Beijing DMS Pharma Ltd.
- Groupe Pasteur Mutualité
- National Cancer Institute (NCI)
- AstraZeneca
- View Full List
Medical Conditions
- Blood Coagulation Disorder Due to Liver Disease
- Hypertension
- Corpus Callosum Malformation
- Asthma
- Leucocytosis
- Gastroesophageal Reflux Disease With Dyspepsia Symptoms
- Pain
- ASA 1-2 Requiring Intravenous Cannulation for General Anaesthesia
- Prostate Cancer
- Breast Cancer
- Hematopoietic and Lymphoid Cell Neoplasm
- Blood Flow Indexes
- Infection Gastrointestinal
- Nutritional Status in Hospitalised Geriatric Patients
- Depression
- Obesity
- Coronary Artery Disease
- Pre-terminal Cancer
- HIV Infections
- Stroke
- View Full List
Drug Interventions
- Prednisone
- Cyclophosphamide
- Efficacy of Enbrel subcutaneously at Week 36
- Dicofenac
- Esketamine Hydrochloride 28 Mg in 0.2 mL NASAL SOLUTION [Spravato]
- Paclitaxel
- Capecitabine
- AC-150A 0.1%
- Gemcitabine
- Dexamethasone
- Cisplatin
- enalapril and other angiotensin converting enzyme inhibitors; losartan and other angiotensin receptor blockers
- M4344 10 mg BIW
- 100 mg INX-08189 QD
- Iodixanol, Ioversol, Iopromide
- CA-008
- Carboplatin
- Bevacizumab
- Triamcinolone Acetonide 4 mg intravitreal injection
- docetaxel
- View Full List
CROs by country
- Contract Research Organizations in Austria
- Contract Research Organizations in Croatia
- Contract Research Organizations in Gambia
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Hungary
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Kenya
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Norway
- Contract Research Organizations in Russia
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Uganda
- Contract Research Organizations in Uruguay
- CRO list by country